甲磺酸伊马替尼联合塞来昔布对胃肠间质瘤细胞增殖及凋亡的影响(3)
 |
| 第1页 |
参见附件。
[2] Bauer S，Duensing A，Demetri GD，et al.KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor：PI3-kinase/AKT is a crucial survival pathway[J].Oncogene，2007，26(54)： 7560-7568.
[3] Stewart AE，Heslin MH，Arch J， et al. Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors[J].J Gastrointest Surg，2006，10(2)：315-319.
[4] Kawai N，Tsujii M，Tsuji S.Cyclooxygenases and colon cancer[J].Prostaglandins Other Lipid Mediat，2002，68-69：187-196.
[5] Tsujii M，DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J].Cell，1995，83(3)：493-501.
[6] Tsujii M，Kawano S，Tsuji S，et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J].Cell，1998，93(5)：705-716.
[7] Turkoz HK，Alkan I，Sisman S，et al. Cyclooxygenase-2 expression and connection with tumor recurrence and histopathologic parameters in gastrointestinal stromal tumors[J].APMIS，2009，117(11)：825-830.
[8] Miao R，Liu N，Wang Y，et al. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor： possible relations to pathological parameters and clinical behavior[J].Hepatogastroenterology，2008，55(88)：2012-2015.
[9] Tuveson DA，Willis NA，Jacks T，et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein：biological and clinical implications[J].Oncogene，2001，20(36)：5054-5058.
(收稿日期：2012-08-16)
您现在查看是摘要介绍页，详见PDF附件。